Swedish Orphan Biovit Ord
(BIOVF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 508,283 | 601,202 | 644,471 | 478,040 | 462,840 |
| Cost of Goods | 121,887 | 148,859 | 130,643 | 108,040 | 130,340 |
| Gross Profit | 386,302 | 452,343 | 513,735 | 370,093 | 332,500 |
| Operating Expenses | 330,029 | 327,022 | 363,895 | 319,443 | 293,510 |
| Operating Income | 57,161 | 126,179 | 150,669 | 50,598 | 39,235 |
| Interest Expense | 31,476 | 31,809 | 40,347 | 39,868 | 13,110 |
| Other Income | 0 | 0 | 4,715 | 0 | 0 |
| Pre-tax Income | 25,685 | 94,370 | 115,037 | 10,730 | 26,125 |
| Income Tax | 4,763 | 17,490 | 19,658 | 2,035 | 5,130 |
| Net Income Continuous | 20,922 | 76,880 | 95,379 | 8,695 | 20,995 |
| Net Income | $20,922 | $76,880 | $95,379 | $8,695 | $21,090 |
| EPS Basic Total Ops | 0.06 | 0.23 | 0.26 | 0.03 | 0.07 |
| EPS Basic Continuous Ops | 0.06 | 0.23 | 0.26 | 0.03 | 0.07 |
| EPS Diluted Total Ops | 0.06 | 0.22 | 0.26 | 0.03 | 0.07 |
| EPS Diluted Continuous Ops | 0.06 | 0.22 | 0.26 | 0.03 | 0.07 |
| EPS Diluted Before Non-Recurring Items | 0.07 | 0.26 | 0.30 | N/A | N/A |
| EBITDA(a) | $140,261 | $213,534 | $245,413 | $133,925 | $99,447 |